Mandara Biopharma's IND Submission for Dronabinol in Alzheimer's Agitation Treatment Marks a Pivotal Step Discover how Mandara Biopharma is advancing a new oral solution of dronabinol to treat agitation in Alzheimer's patients through its recent IND filing with the FDA.

Mandara Biopharma's IND Submission for Dronabinol in Alzheimer's Agitation Treatment Marks a Pivotal Step #United_States #Boulder #Alzheimer's_Treatment #Mandara_Biopharma #Dronabinol